Comprehensive evaluation of microneedle‐based intradermal adalimumab delivery vs. subcutaneous administration: results of a randomized controlled clinical trial

AIMS: To evaluate feasibility of intradermal (i.d.) adalimumab administration using hollow microneedles, and to compare a single i.d. dose of adalimumab using a hollow microneedle with a single subcutaneous (s.c.) dose using a conventional needle. METHODS: In this single‐centre double‐blind, placebo...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobse, Justin, ten Voorde, Wouter, Tandon, Anushka, Romeijn, Stefan G., Grievink, Hendrika W., van der Maaden, Koen, van Esdonk, Michiel J., Moes, Dirk Jan A.R., Loeff, Floris, Bloem, Karien, de Vries, Annick, Rispens, Theo, Wolbink, Gertjan, de Kam, Marieke, Ziagkos, Dimitrios, Moerland, Matthijs, Jiskoot, Wim, Bouwstra, Joke, Burggraaf, Jacobus, Schrier, Lenneke, Rissmann, Robert, ten Cate, Rebecca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359405/
https://www.ncbi.nlm.nih.gov/pubmed/33403697
http://dx.doi.org/10.1111/bcp.14729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359405/
https://www.ncbi.nlm.nih.gov/pubmed/33403697
http://dx.doi.org/10.1111/bcp.14729

Ejemplares similares